Dashboard
Manage Tickers

SRPT


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

insperity-posts-downbeat-q3-results-joins-iac-archer-daniels-midland-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session
Insperity Posts Downbeat Q3 Results, Joins...
11/04/2025 14:00:14

Core News & Articles
Market-Moving News for November 4th
11/04/2025 12:24:43

PRLD: 70% | Prelude Therapeutics Signs Agreement For Incyte To Acquire JAK2V617F JH2 Inhibitor Program In Development For Patie...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
11/04/2025 12:05:48

why-upwork-shares-are-trading-higher-by-over-22-here-are-20-stocks-moving-premarket
Why Upwork Shares Are Trading Higher By Ov...
11/04/2025 11:22:41

sarepta-therapeutics-stock-is-tumbling-after-the-close-heres-why
Sarepta Therapeutics Stock Is Tumbling Aft...
11/03/2025 22:00:54

Sarepta shares are plunging in extended trading Monday after the company reports third-quarter results and provided an update o...

sarepta-therapeutics-says-essence-study-did-not-achieve-statistical-significance-on-its-primary-endpoint-says-the-study-was-impacted-by-the-covid-19-pandemic-and-when-covid-impacted-data-is-excluded-meaningful-treatment-effect-is-seen-on-the-primary-endpoint
Sarepta Therapeutics Says ESSENCE Study Di...
11/03/2025 21:26:27

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
11/03/2025 21:12:06

sarepta-therapeutics-q3-adj-eps-013-beats-081-estimate-sales-399356m-beat-338710m-estimate
Sarepta Therapeutics Q3 Adj. EPS $(0.13) B...
11/03/2025 21:09:02

Sarepta Therapeutics (NASDAQ:SRPT) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of ...

top-stocks-with-earnings-this-week-joby-ionq-amd-and-more
Top Stocks With Earnings This Week: Joby, ...
11/03/2025 14:14:07

Retail investors are preparing for another busy week of earnings season with more than 1,600 companies set to report through Fr...

earnings-scheduled-for-november-3-2025
Earnings Scheduled For November 3, 2025
11/03/2025 11:11:31

a-peek-at-sarepta-therapeuticss-future-earnings
A Peek at Sarepta Therapeutics's Future Ea...
10/31/2025 18:02:57

piper-sandler-maintains-neutral-on-sarepta-therapeutics-raises-price-target-to-16
Piper Sandler Maintains Neutral on Sarepta...
10/30/2025 13:39:00

Piper Sandler analyst Biren Amin maintains Sarepta Therapeutics (NASDAQ:SRPT) with a Neutral and raises the price target fro...

tradr-launches-9-single-stock-2x-etfs-with-first-of-its-kind-opendoor-gold-and-ai-exposure
Tradr Launches 9 Single-Stock 2X ETFs With...
10/23/2025 18:27:16

The new ETFs include the first-of-their-kind gold and AI plays, giving traders targeted exposure without using margin or comple...

whats-going-on-sarepta-stock-on-wednesday
What's Going On Sarepta Stock On Wednesday?
10/08/2025 15:19:16

Sarepta prepares to present new data on Duchenne and limb-girdle muscular dystrophy gene therapy programs this week.

sarepta-therapeutics-to-present-results-from-emergene-phase-3-study-on-expression-of-sgcb-and-safety-following-bidridistrogene-xeboparvovec-treatment-in-patients-with-lgmd2er4-at-wms-2025-congress
Sarepta Therapeutics To Present Results Fr...
10/03/2025 12:36:01

taysha-gene-therapies-canaan-ondas-holdings-and-other-big-stocks-moving-higher-on-thursday
Taysha Gene Therapies, Canaan, Ondas Holdi...
10/02/2025 16:29:57

U.S. stocks were mixed, with the Dow Jones index falling more than 50 points on Thursday.

watching-sarepta-therapeutics-shares-are-moving-higher-traders-circulate-linkedin-post-from-us-fda-drug-regulator-george-tidmarsh
Watching Sarepta Therapeutics; Shares Are ...
09/29/2025 17:09:31

https://www.linkedin.com/posts/george-f-tidmarsh-972061b_cder-will-be-evaluating-surrogate-endpoints-activity-73783970832230563...

this-sarepta-therapeutics-analyst-turns-bullish-here-are-top-5-upgrades-for-monday
This Sarepta Therapeutics Analyst Turns Bu...
09/22/2025 12:43:32

bmo-capital-upgrades-sarepta-therapeutics-to-outperform-maintains-price-target-to-50
BMO Capital Upgrades Sarepta Therapeutics ...
09/22/2025 11:21:53

BMO Capital analyst Kostas Biliouris upgrades Sarepta Therapeutics (NASDAQ:SRPT) from Market Perform to Outperform and maint...

expert-outlook-sarepta-therapeutics-through-the-eyes-of-43-analysts
Expert Outlook: Sarepta Therapeutics Throu...
09/15/2025 14:02:08

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION